Product Information
TRIAZOLAM 0.125 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.2791 per EA under NDC 50742064501. Its NADAC has been published 282 times since Mar 31, 2021.
FDA first approved this application on Oct 20, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.125 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742064501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TRIAZOLAMApproval Type
Generic (ANDA)
FDA Application
ANDA214219FDA Approved
10/20/2020
TE Code
AB
On Market Since
10/20/2020
Pharmacological Classes
Price Statistics
The NADAC for TRIAZOLAM 0.125 MG TABLET has been published 282 times since Mar 31, 2021, and over the history we have for it it has declined 79.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2791 per EA |
|---|---|
| All-time high | $1.5231 (Apr 13, 2022) |
| All-time low | $0.2219 (Jan 22, 2025) |
| 52-week high | $0.3975 |
| 52-week low | $0.2791 |
| Median price | $0.8000 |
| Average price | $0.7072 |
| Largest weekly change | +49.3% (Mar 23, 2022) |
| Weeks tracked | 282 |
| Tracking since | Mar 31, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRIAZOLAM 0.125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRIAZOLAM 0.125 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.2791 per EA (NDC 50742064501), effective Aug 19, 2026.
How has the price of TRIAZOLAM 0.125 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRIAZOLAM 0.125 MG TABLET has declined 79.1%. It has been tracked across 282 weekly CMS publications since Mar 31, 2021.
What are the highest and lowest recorded NADAC prices for TRIAZOLAM 0.125 MG TABLET?
Since Mar 31, 2021, the NADAC for TRIAZOLAM 0.125 MG TABLET has ranged from a low of $0.2219 (Jan 22, 2025) to a high of $1.5231 (Apr 13, 2022), with a median of $0.8000 per EA.
Are there cheaper alternatives to TRIAZOLAM 0.125 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TRIAZOLAM 0.125 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TRIAZOLAM 0.125 MG TABLET?
TRIAZOLAM 0.125 MG TABLET (NDC 50742064501) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.